Moneycontrol
Get App
SENSEX NIFTY
you are here:

Glenmark Pharma Ltd.

BSE: 532296 | NSE: GLENMARK |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE935A01035 | SECTOR: Pharmaceuticals

Success
Alert
Please select a Day.
Info

BSE Live

Jan 24, 16:00
350.80 0.10 (0.03%)
Volume
AVERAGE VOLUME
5-Day
76,410
10-Day
60,571
30-Day
65,895
34,894
  • Prev. Close

    350.70

  • Open Price

    350.00

349.75

Today’s L/H

355.85
267.30

52 Wk L/H

668.25
315.65

L/U Price Band

385.75
  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

  •  VWAP

    353.03
     Beta
    0.52
  • Market Depth (24 Jan 2020)

    BUYSELL
    QTY PRICE PRICE QTY
    450 350.10 350.55 33
    87 349.65 350.90 450
    217 349.60 351.05 87
    540 349.55 351.10 125
    1677 349.50 351.40 217
    0 Total Total 0
     Market Depth
    BUY 0
    SELL 0
    0%
    0%

NSE Live

Jan 24, 15:57
350.75 -0.15 (-0.04%)
Volume
AVERAGE VOLUME
5-Day
2,187,185
10-Day
1,780,104
30-Day
1,597,721
1,121,453
  • Prev. Close

    350.90

  • Open Price

    349.10

349.10

Today’s L/H

356.00
267.25

52 Wk L/H

666.80
315.85

L/U Price Band

385.95
  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

  •  VWAP

    353.23
     Beta
    0.58
  • DELIVERY AVERAGES
    3-Day
    20.53%
    5-Day
    23.88%
    8-Day
    26.11%
    Deliverables
  • SMA
    30
    348.09
    50
    344.07
    150
    366.80
    200
    423.96
    SMA
    348.09
Parameters
NSE
BSE
Bid Price
0.00
0.00
Bid Qty
0
0
Offer Price
0.00
0.00
Offer Qty
0
0
Today's Low
349.10
349.75
Today's High
356.00
355.85
52 Wk Low
267.25
267.30
52 Wk High
666.80
668.25
Open Price
349.10
350.00
Prev. Close
350.90
350.70
Expiry Date
351.25 -0.85 ( -0.24 % )
Parameters
NSE
Open Price
350.30
High Price
356.65
Low Price
349.70
Prev. Close
352.10
Average Price
354.30
No. of Contracts Traded
2
Turnover (Rs. In Lakhs)
10,237.85
Market Lot
1400
Open Interest
5,889,800
Open Interest Change
-1,047,200
Open Interest Change %
-15.10
Expiry Date
Option Type
Strike Price
351.25 -0.85 ( -0.24 % )
Parameters
NSE
Open Price
350.30
High Price
356.65
Low Price
349.70
Prev. Close
352.10
Average Price
354.30
No. of Contracts Traded
2
Turnover (Rs. In Lakhs)
10,237.85
Market Lot
1400
Open Interest
5,889,800
Open Interest Change
-1,047,200
Open Interest Change %
-15.10

Charts

  • Open : -
  • High : -
  • Low -
  • Close: -
  • Volume -

TECHNICAL ANALYSIS

TECHNICAL RATING
Bullish
Moving Averages Bullish
Technical Indicators Neutral
Moving Averages Crossovers Bullish
Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 354.80 358.85 361.70 351.95 347.90 345.05 341.00
Fibonacci 354.59 356.21 358.85 351.95 349.31 347.69 345.05
Camarilla 351.38 352.01 352.65 351.95 350.12 349.49 348.85

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

SIMPLE MOVING AVERAGES
Days NSE
5 350.68
10 349.82
20 348.00
50 344.07
100 336.02
200 423.96
Pivot levels

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 371.02 382.08 398.97 354.13 343.07 326.18 315.12
Fibonacci 364.81 371.41 382.08 354.13 343.46 336.86 326.18
Camarilla 362.51 365.07 367.64 354.13 357.39 354.83 352.26

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

SIMPLE MOVING AVERAGES
Pivot levels

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 363.77 380.08 400.67 343.18 326.87 306.28 289.97
Fibonacci 357.28 365.99 380.08 343.18 329.09 320.38 306.28
Camarilla 350.83 354.21 357.60 343.18 344.07 340.69 337.30

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

SIMPLE MOVING AVERAGES
Pivot levels

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

Valuation

    • Market Cap (Rs Cr.)
      9,898.46
    • P/E
      8.71
    • Book Value (Rs)
      423.23
    • Dividend (%)
      200.00
    • Market Lot
      1
    • Industry P/E
      30.95
    • EPS (TTM)
      40.29
    • P/C
      7.96
    • Price/Book
      0.83
    • Dividend Yield.(%)
      0.57
    • Face Value (RS)
      1.00
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      20.53
      5-Day
      23.88
      8-Day
      26.11
      24.66

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

    • Market Cap (Rs Cr.)
      9,898.46
    • P/E
      15.40
    • Book Value (Rs)
      198.63
    • Dividend (%)
      200.00
    • Market Lot
      1
    • Industry P/E
      30.95
    • EPS (TTM)
      22.78
    • P/C
      10.22
    • Price/Book
      1.77
    • Dividend Yield.(%)
      0.57
    • Face Value (RS)
      1.00
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      20.53
      5-Day
      23.88
      8-Day
      26.11
      24.66

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

F&O QUOTE

NSE 351.25 -0.85 (-0.24%)
Instrument Type
Expiry Date
Option Type
Strike Price
    • Open Price
      350.30
    • High Price
      356.65
    • Low Price
      349.70
    • Prev. Close
      352.10
    • Average Price
      354.30
    • No. of Contracts Traded
      2
    • Turnover (Rs. In Lakhs)
      10,237.85
    • Market Lot
      1400

Forum

Community Sentiments

  • 60% BUY
  • 20% SELL
  • 20% HOLD
60%
of moneycontrol users recommend buying Glenmark

What's your call on Glenmark today?

Read 1 investor views

BUY SELL HOLD

Action in Glenmark Pharma Ltd.

Pre-Opening Session Prices9:00 am - 9:15 am

BSE - No shares traded

NSE

Jan 26, 09:15
349.10 -1.80 (-0.51%)
High 350.70
Low 349.10
Prev. Close 350.90

Financials

Income Statement

  Sep 2019 Jun 2019 Mar 2019 Dec 2018 Sep 2018
Net Sales 1,742.62 1,455.23 1,530.76 1,599.90 1,639.81
Other Income 192.47 68.54 168.39 -84.64 226.30
PBDIT 380.53 308.64 268.74 349.36 391.82
Net Profit 431.99 227.84 281.29 195.87 747.56
  Sep 2019 Jun 2019 Mar 2019 Dec 2018 Sep 2018
Net Sales 2,763.73 2,283.60 2,526.08 2,509.78 2,539.86
Other Income 80.83 1.67 39.06 -109.02 139.88
PBDIT 450.41 341.90 364.12 434.69 440.10
Net Profit 255.54 109.28 161.66 116.34 414.00

Balance Sheet

Standalone Mar 2019 Mar 2018
Total Share Capital 28.22 28.22
Networth 11,942.09 10,391.44
Total Debt 3,134.48 2,981.07
Net Block 1,413.48 1,699.12
Investments 3,268.75 3,212.68
Total Assets 15,076.56 13,372.51

Historical Prices

On
Current Price %Gain / Loss
Open Price 651.15 350.00
-46.25
High Price 658.70 355.85
-45.98
Low Price 641.65 349.75
-45.49
Close Price 649.30 350.70
-45.99
Volume 31,973 34,894
9.14
On
Current Price %Gain / Loss
Open Price 653.95 349.10
-46.62
High Price 658.00 356.00
-45.9
Low Price 641.70 349.10
-45.6
Close Price 649.75 350.90
-45.99
Volume 523,889 1,121,453
114.06
Click Here to view the Open, High, Low, Close, Volume and Historic data for
Index Price Change %Chg
NIFTY 50 12248.30 67.90 0.56
SENSEX 41613.19 226.79 0.55
NIFTY BANK 31241.75 237.75 0.77
NIFTY IT 16472.75 -1.65 -0.01
S&P BSE Smallcap 14845.96 73.64 0.50
Index Price Change %Chg
Nasdaq (Jan 25) 9,314.91 -87.57 -0.93
DAX (Jan 24) 13,576.68 188.26 1.41
CAC (Jan 24) 6,024.26 52.47 0.88
FTSE (Jan 24) 7,585.98 78.31 1.04
SGX Nifty (Jan 25) 12,229.00 -43.50 -0.35

CORPORATE ACTION

Date Agenda
Nov 14, 2019 Quarterly Results
Aug 13, 2019 Quarterly Results
May 29, 2019 Others
Feb 14, 2019 Quarterly Results
Type Dividend% Ex-Dividend date
Final 200.00 Sep 19, 2019
Final 200.00 Sep 19, 2018
Final 200.00 Sep 20, 2017
Final 200.00 Aug 03, 2016
Final 200.00 Sep 10, 2015
Ratio Announcement Date Ex-Bonus
1:1 Jan 06, 2005 Mar 04, 2005
Old FV New FV Ex-Split
2 1 Sep 10, 2007
10 2 Oct 23, 2003
Ratio Premium Ex-Bonus
No Rights Information is available for Glenmark Pharma
Date Agenda
Sep 27, 2019 -
Sep 27, 2018 -
Sep 28, 2018 -
Sep 29, 2017 -
Aug 12, 2016 Rs.2.0000 per share(200%)Dividend

Dividend Summary

For the year ending March 2019 Glenmark Pharma has declared an equity dividend of 200.00% amounting to Rs 2 per share. At the current share price of Rs 350.75 this results in a dividend yield of 0.57%.

The company has a good dividend track report and has consistently declared dividends for the last 5 years.

SHARE HOLDING PATTERN & MUTUAL FUND HOLDING

Share Holding Pattern in (%)

Standalone June 2019 December 2018 September 2018 June 2018
Promoters 46.58 46.54 46.54 46.54
Pledged 0 0 0 0
FII/FPI 31.04 32.27 30.9 30.61
Total DII 13.05 11.85 12.75 12.16
Fin.Insts 2.62 2.72 2.82 2.74
Insurance Co 0 0 0 0
MF 4.88 4.02 4.28 4.01
Others DIIs 5.55 5.11 5.65 5.41
Others 9.35 9.34 9.82 10.7
Total 100.02 100 100.01 100.01

PEERS COMPARISON

Company Name Last Price % Change 52 Wk High 52 Wk Low Market Cap Sales Qtr Net Profit Qtr
Glenmark 350.80 0.03 667.00 267.30 9898.46 6,304.87 1,622.11
Sun Pharma 447.70 -0.49 484.10 350.40 107418.23 10,303.21 816.60
Divis Labs 1912.10 0.76 1925.25 1460.55 50760.25 4,879.66 1,332.65
Dr Reddys Labs 3028.05 -0.34 3105.00 2065.30 50315.03 10,625.50 1,277.30
Cipla 458.10 -1.44 585.50 389.55 36933.29 12,374.01 1,888.41

COMPANY OVERVIEW

Glenmark Pharmaceuticals Ltd has a significant presence in the branded generics markets across emerging economies including India.The company entered into the dermatology market through the launch of its Candid Cream.Glenmarks ground-breaking drug discovery effort is primarily focused in the areas of inflammation [asthma/COPD, rheumatoid arthritis etc.], metabolic disorders [diabetes, obesity, etc.] and pain [neuropathic pain and inflammatory pain].The formulations business of the company focuses on therapeutic areas viz. dermatology, anti-infective, respiratory, cardiac, diabetes, gynecology, CNS, and oncology. India is the largest market in terms of revenue for the organization.

COMPANY INFORMATION

  • Registered Office

  • Registrars

    • Name

      Karvy Computershare Private Ltd.

    • Address

      Plot no. 31-32, GachibowliFinancial DistrictNanakramguda

    • City

      Hyderabad 500032

    • State

      Telangana

    • Tel. No.

      040-23001153

    • Fax No.

    • Email

    • Internet

  • Management

    • Name

      Designation

    • Glenn Saldanha

      Chairman & Managing Director

    • V S Mani

      Executive Director & Global CFO

    • Rajesh V Desai

      Non Executive Director

    • B E Saldanha

      Non Executive Director

    • Bernard Munos

      Ind. Non-Executive Director

  • Listing

    Whether The Company Forms A Part Of The Following Indices -
    • Sensex

      No

    • Nifty

      No

    • Bse-100

      Yes

    • Bse-200

      Yes

    • S&P CNX 500

      Yes

    • CNX Midcap

      Yes

About Glenmark Pharma Ltd.

Glenmark is in the Pharmaceuticals sector.

It is listed on the BSE with a BSE Code of 532296 and the NSE with an NSE Code of GLENMARK.

Related Searches